154 related articles for article (PubMed ID: 28211608)
1. Preclinical characterization of 55P0251, a novel compound that amplifies glucose-stimulated insulin secretion and counteracts hyperglycaemia in rodents.
Stadlbauer K; Brunmair B; Lehner Z; Adorjan I; Scherer T; Luger A; Bauer L; Fürnsinn C
Diabetes Obes Metab; 2017 Aug; 19(8):1088-1096. PubMed ID: 28211608
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
3. Evidence that the multiflorine-derived substituted quinazolidine 55P0251 augments insulin secretion and lowers blood glucose via antagonism at α
Lehner Z; Stadlbauer K; Brunmair B; Adorjan I; Genov M; Kautzky-Willer A; Scherer T; Scheinin M; Bauer L; Fürnsinn C
Diabetes Obes Metab; 2020 Mar; 22(3):290-302. PubMed ID: 31608542
[TBL] [Abstract][Full Text] [Related]
4. PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice.
Lee S; Youn YS; Lee SH; Byun Y; Lee KC
Diabetologia; 2006 Jul; 49(7):1608-11. PubMed ID: 16586064
[TBL] [Abstract][Full Text] [Related]
5. A Novel Diphenylthiosemicarbazide Is a Potential Insulin Secretagogue for Anti-Diabetic Agen.
Sugawara K; Honda K; Reien Y; Yokoi N; Seki C; Takahashi H; Minami K; Mori I; Matsumoto A; Nakaya H; Seino S
PLoS One; 2016; 11(10):e0164785. PubMed ID: 27764176
[TBL] [Abstract][Full Text] [Related]
6. Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein.
Glaesner W; Vick AM; Millican R; Ellis B; Tschang SH; Tian Y; Bokvist K; Brenner M; Koester A; Porksen N; Etgen G; Bumol T
Diabetes Metab Res Rev; 2010 May; 26(4):287-96. PubMed ID: 20503261
[TBL] [Abstract][Full Text] [Related]
7. β-Cell signalling and insulin secretagogues: A path for improved diabetes therapy.
Seino S; Sugawara K; Yokoi N; Takahashi H
Diabetes Obes Metab; 2017 Sep; 19 Suppl 1():22-29. PubMed ID: 28880474
[TBL] [Abstract][Full Text] [Related]
8. Hepatic portal vein denervation impairs oral glucose tolerance but not exenatide's effect on glycemia.
Ionut V; Castro AV; Woolcott OO; Stefanovski D; Iyer MS; Broussard JL; Burch M; Elazary R; Kolka CM; Mkrtchyan H; Bediako IA; Bergman RN
Am J Physiol Endocrinol Metab; 2014 Oct; 307(8):E644-52. PubMed ID: 25117408
[TBL] [Abstract][Full Text] [Related]
9. Dapagliflozin improves insulin resistance and glucose intolerance in a novel transgenic rat model of chronic glucose overproduction and glucose toxicity.
Joannides CN; Mangiafico SP; Waters MF; Lamont BJ; Andrikopoulos S
Diabetes Obes Metab; 2017 Aug; 19(8):1135-1146. PubMed ID: 28244693
[TBL] [Abstract][Full Text] [Related]
10. 55P0110, a Novel Synthetic Compound Developed from a Plant Derived Backbone Structure, Shows Promising Anti-Hyperglycaemic Activity in Mice.
Brunmair B; Lehner Z; Stadlbauer K; Adorjan I; Frobel K; Scherer T; Luger A; Bauer L; Fürnsinn C
PLoS One; 2015; 10(5):e0126847. PubMed ID: 25973898
[TBL] [Abstract][Full Text] [Related]
11. Polysaccharide isolated from Triticum aestivum stimulates insulin release from pancreatic cells via the ATP-sensitive K+ channel.
Lee SH; Lim SW; Lee YM; Lee HS; Kim DK
Int J Mol Med; 2012 May; 29(5):913-9. PubMed ID: 22322245
[TBL] [Abstract][Full Text] [Related]
12. Biophysical and pharmacological properties of glucagon-like peptide-1 in rats under isoflurane anesthesia.
Kawano T; Tanaka K; Chi H; Eguchi S; Yamazaki F; Kitamura S; Kumagai N; Yokoyama M
Anesth Analg; 2012 Jul; 115(1):62-9. PubMed ID: 22504208
[TBL] [Abstract][Full Text] [Related]
13. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
[TBL] [Abstract][Full Text] [Related]
14. MK-626, a dipeptidyl peptidase-4 inhibitor, does not improve the hyperglycemia or hyperinsulinemia of nonobese diabetic MKR mice.
Bhattacharjee A; Allister EM; Wheeler MB
Can J Physiol Pharmacol; 2012 May; 90(5):663-8. PubMed ID: 22530993
[TBL] [Abstract][Full Text] [Related]
15. Poly-GLP-1, a novel long-lasting glucagon-like peptide-1 polymer, ameliorates hyperglycaemia by improving insulin sensitivity and increasing pancreatic beta-cell proliferation.
Ma X; Hui H; Liu Z; He G; Hu J; Meng J; Guan L; Luo X
Diabetes Obes Metab; 2009 Oct; 11(10):953-65. PubMed ID: 19531053
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological approach to understanding the control of insulin secretion in human islets.
Henquin JC; Dufrane D; Gmyr V; Kerr-Conte J; Nenquin M
Diabetes Obes Metab; 2017 Aug; 19(8):1061-1070. PubMed ID: 28116849
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, and pharmacokinetic studies of PEGylated glucagon-like peptide-1.
Lee SH; Lee S; Youn YS; Na DH; Chae SY; Byun Y; Lee KC
Bioconjug Chem; 2005; 16(2):377-82. PubMed ID: 15769092
[TBL] [Abstract][Full Text] [Related]
18. Meal feeding improves oral glucose tolerance in male rats and causes adaptations in postprandial islet hormone secretion that are independent of plasma incretins or glycemia.
Vahl TP; Aulinger BA; Smith EP; Drazen DL; Ulrich-Lai Y; Seeley RJ; Woods SC; D'Alessio DA
Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E784-92. PubMed ID: 25159330
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide (P32/98) in fatty Zucker rats with incipient and manifest impaired glucose tolerance.
Augstein P; Berg S; Heinke P; Altmann S; Salzsieder E; Demuth HU; Freyse EJ
Diabetes Obes Metab; 2008 Sep; 10(10):850-61. PubMed ID: 17970756
[TBL] [Abstract][Full Text] [Related]
20. A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents.
Nørregaard PK; Deryabina MA; Tofteng Shelton P; Fog JU; Daugaard JR; Eriksson PO; Larsen LF; Jessen L
Diabetes Obes Metab; 2018 Jan; 20(1):60-68. PubMed ID: 28598027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
